Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
Elon Musk-owned Starlink will need fresh approval from India’s space regulator IN-SPACe to roll out direct-to-device s...
Indian power company advisers have returned to India from Bangladesh. This follows security concerns amid rising communa...